CCL2 and colitis: In the current study, we detected a significantly higher colonic expression of Ccl2, Cxcl1, Cxcl2, and Cxcr3 genes in the control and RB groups (p < 0.05, RB vs. control) compared to the FRB group, which supports the protective effect of FRB in colitis.